Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.3728 -0.4272 (-1.1%) Market Cap: 5.60 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.90 GF Score: 70/100

Ionis Pharmaceuticals Inc at Needham Healthcare Conference Transcript

Apr 11, 2022 / 02:15PM GMT
Release Date Price: $39.61 (-1.27%)
Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst

Good morning, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Ionis Pharmaceuticals. And joining us today from Ionis is EVP of Research, Eric Swayze. For those of you joining on the webcast, if you want to ask a question, please do so at any time. You can submit a question using the chat box at the bottom of your screen. With that, we'll go ahead and get started. Eric, thank you so much for joining us today.

Eric E. Swayze
Ionis Pharmaceuticals, Inc. - EVP of Research

Great. Thanks, Joey. I appreciate the opportunity to be on and talk about our company a bit.

Questions & Answers

Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst

So Ionis has been one of the leaders in developing RNA-targeted therapeutics for a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot